Not sure if this is the correct thread to post or if it should be moved to the "Coronavirus" thread.
BergenBio which is a Bergen/Oxford-based company with ongoing trials on threatment for Covid. The product, already produced, is Bemcentinib, which they hope will be a threatment for early Covid-infection. The CEO was quoted that it was a 80% chance of it working against Covid, but he later said he was misunderstood. The company is also backed by norwegian billionaire Trond Mohn who actually buys every dip, last time was 4 days ago.
As the new mutants in England comes I think this could be a great momentum-play in the near term, but also a long term hold. They have a wife pipeline as you can see in the link below:
Ticker is BGBIO on Euronext. It is my second biggest holding after TSLA, and the MCAP is around 300 mill dollars.
Bemcentinib Potential First-in-class AXL Inhibitor | TNBC – BerGenBio
BergenBio which is a Bergen/Oxford-based company with ongoing trials on threatment for Covid. The product, already produced, is Bemcentinib, which they hope will be a threatment for early Covid-infection. The CEO was quoted that it was a 80% chance of it working against Covid, but he later said he was misunderstood. The company is also backed by norwegian billionaire Trond Mohn who actually buys every dip, last time was 4 days ago.
As the new mutants in England comes I think this could be a great momentum-play in the near term, but also a long term hold. They have a wife pipeline as you can see in the link below:
Ticker is BGBIO on Euronext. It is my second biggest holding after TSLA, and the MCAP is around 300 mill dollars.
Bemcentinib Potential First-in-class AXL Inhibitor | TNBC – BerGenBio